Sichuan Goldstone Asia Pharmaceutical Inc.

¥12.37As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300434Industrials
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.91%)
Div yield 0.66%
ROE 6.66%
Industrial Distribution
Beta (5Y) 0.54
PE TTM 28.03
TSR TTM 13.68%
Mkt cap ¥4.970B
ROIC 7.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥12
(1.84%)
(8.35%)
Hold 12|12|5|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.31
0.34
0.35
0.39
18.34%
16.56%
21.55%
36.87%
Revenue¥M
265.9
267.7
268.3
267.5
7.45%
5.84%
6.95%
2.49%
Peers (US$745.0M)
Cap (US$)
PE
523.4M
8.747x
338.1M
—
265.6M
77.75x
769.8M
13.94x
Capital
TTM
5Y
10Y
Leveragex
0.657
0.162
0.109
EBIT/Intx
0.502
0.370
0.366
Own earn%
37.20
85.20
82.84
Sh yield%
47.92
21.72
18.45
Owners
Insiders/Inst%
5.33
55.49
Short interest%
1.07
SBC / revenue%
4.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
27–38
$1 testx
—
Incr. ROIC%
15